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Pneumonic plague is a deadly respiratory disease
caused by Yersinia pestis. The bacterial protease
Pla contributes to disease progression and manipu-
lation of host immunity, but the mechanisms by
which this occurs are largely unknown. Here we
show that Pla degrades the apoptotic signaling
molecule Fas ligand (FasL) to prevent host cell
apoptosis and inflammation. Wild-type Y. pestis,
but not a Pla mutant (Dpla), degrades FasL, which
results in decreased downstream caspase-3/7 acti-
vation and reduced apoptosis. Similarly, lungs of
mice challenged with wild-type Y. pestis show
reduced levels of FasL and activated caspase-3/7
compared to Dpla infection. Consistent with a role
for FasL in regulating immune responses,Dpla infec-
tion results in aberrant proinflammatory cytokine
levels. The loss of FasL or inhibition of caspase ac-
tivity alters host inflammatory responses and en-
ables enhanced Y. pestis outgrowth in the lungs.
Thus, by degrading FasL, Y. pestis manipulates
host cell death pathways to facilitate infection.
INTRODUCTION
Infectious pneumonias are a leading cause of worldwide
morbidity and mortality, with a greater annual burden of dis-
ease than HIV, malaria, and tuberculosis (Mizgerd, 2006). The
bacterium Yersinia pestis is an infamous example of an easily
transmitted pathogen that causes respiratory infections. As the
deadliest form of disease caused by Y. pestis, primary pneu-
monic plague results in a rapidly progressing, purulent, multi-
focal severe exudative bronchopneumonia, and is 100% fatal
if untreated (Lathem et al., 2005; Perry and Fetherston, 1997).
A hallmark of pneumonic plague is the strikingly biphasic
pulmonary host inflammatory response. The first 24 hr following
infection are characterized by rapid bacterial replication in
the absence of inflammation. By 36 hr, however, the infection
rapidly transitions to a highly proinflammatory phase that is
marked by extensive immune cell influx, inflammatory cytokine
production, and tissue damage (Lathem et al., 2005; Price
et al., 2012).424 Cell Host & Microbe 15, 424–434, April 9, 2014 ª2014 Elsevier InY. pestis produces multiple virulence factors to suppress the
initial host inflammatory response, including a tetra-acylated
form of LPS, antiphagocytic surface proteins, and a type III
secretion system (T3SS) that injects multiple toxins into host
cells (Montminy et al., 2006; Perry and Fetherston, 1997). These
effects are broad—for instance, the T3SS effector protein YopK
induces macrophage apoptosis early during infection, while
YopM inhibits the activation of caspase-1 to prevent cell death
via pyroptosis (LaRock and Cookson, 2012; Peters et al.,
2013). Indeed, these concerted functions permit Y. pestis to
evade early detection by the host even in the presence of other-
wise stimulatory signals such as PAMPs. As the infection transi-
tions into the proinflammatory phase, however, it is believed
that host cell apoptosis declines while pyroptosis or other forms
of inflammatory cell death increase (Bergsbaken and Cookson,
2007). In spite of these anti-inflammatory factors the bacteria
are eventually detected by the host and massive inflammation
ensues.
Previous work has shown that the Y. pestis bacterial plasmin-
ogen activator protease Pla also contributes to the manipulation
of host inflammation during pneumonic plague (Lathem et al.,
2007), although the mechanisms by which this occurs have not
yet been elaborated. Pla is a member of the omptin family of
bacterial outer membrane proteases and has been shown to
cleave a number of host substrates in vitro, including plasmin-
ogen, a2-antiplasmin, and other factors integral to coagulation
and fibrinolysis (Caulfield and Lathem, 2012). Indeed, Pla is
required for the full virulence of Y. pestis during both bubonic
and pneumonic plague (Lathem et al., 2007; Sodeinde et al.,
1992). Pla activates host fibrinolysis during bubonic plague to
enable dissemination from the skin to distal sites (Degen et al.,
2007), and during pneumonic plague, Pla is required for the
massive outgrowth of bacteria observed in the lower airways
and is maximally expressed during the proinflammatory phase
of disease (Lathem et al., 2007, 2014). Themechanisms bywhich
Pla contributes to bubonic versus pneumonic plague may be
distinct, however, and the host proteins cleaved by Pla in the
lungs to alter inflammation and enhance disease during pneu-
monic plague are not yet known.
FasL is a type II membrane protein within the TNF family of
death factors (Nagata, 1997). By engaging with the canonical
death receptor Fas on cell surfaces, FasL initiates host cell death
through the downstream activation of caspase-8 followed by
caspase-3/7 as part of the extrinsic apoptosis pathway (Nagata,
1997). FasL has traditionally been recognized to play roles in
T cell homeostasis and the elimination of tumor cells, yet isc.
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cells in the lungs during infection (Hamann et al., 1998; Xerri
et al., 1997). FasL has recently been appreciated for its protec-
tive role in the lungs during bacterial pneumonias by mediating
inflammation and innate immune cell recruitment (Yeretssian
et al., 2008). Via Fas signaling, the host induces apoptotic cell
death as a mechanism to optimize innate inflammatory re-
sponses for defense while avoiding excessive pulmonary
damage (Labbe´ and Saleh, 2008). For instance, apoptosis is
associated with increased bacterial clearance during infection
with Streptococcus pneumoniae (Daigneault et al., 2012), and
infection with either Pseudomonas aeruginosa or Helicobacter
pylori leads to increased FasL-dependent apoptosis of host cells
and increased disease severity among FasL-deficient mice as
compared to wild-type controls (Grassme´ et al., 2000; Jones
et al., 2002). Here we report that through the activity of Pla,
Y. pestis inactivates the host signaling molecule Fas ligand
(FasL) to alter host cell death pathways and to modulate innate
inflammatory responses during pneumonic plague, which results
in increased virulence of the pathogen during infection.
RESULTS
Identification of Fas Ligand as a Substrate of Pla
In order to identify host factors that, when cleaved by Pla, could
influence the host inflammatory response to Y. pestis infection in
the lungs, we undertook a proteomic-scale approach as ameans
of substrate discovery. Specifically, we used commercially avail-
able microarray slides that contained 3,525 unique 8–15 residue
peptides of random amino acid sequence as well as sequences
frompreviously annotated protease cleavage sites (Figure 1A). In
order to obtain active Pla protein to use with this array, we
purified a recombinant form of full-length Pla with an N-terminal
6xHis tag. His-Pla protein was subsequently activated by incu-
bation with rough LPS as previously described (see Figures
S1A and S1B available online) (Kukkonen et al., 2001).
After incubation of the microarray with His-Pla and subse-
quent detection with fluorescently conjugated antibodies, we
found that 4.8% (170 of 3,525) of the peptides were cleaved
by Pla (Table S1). This approach for substrate discovery was
internally validated by the cleavage of peptides representing
the previously identified Pla substrates plasminogen and a2-anti-
plasmin. In addition, we observed a reduction in fluorescence
from spots with sequences corresponding to amino acids 126–
133 of the host apoptotic signaling protein FasL, suggesting
that this molecule may represent a previously unknown Pla
substrate.
Pla Is Necessary and Sufficient to Degrade Fas Ligand
To validate FasL as a substrate of Pla under native conditions
(i.e., in the presence of whole bacteria), we incubated purified
human FasL, consisting of the extracellular domain of the
protein, with either Y. pestis or an isogenic mutant of Y. pestis
lacking Pla (Y. pestis Dpla). We observed a time-dependent
loss of detectable FasL by immunoblot when treated with
Y. pestis, but not the Dpla mutant, confirming that the degrada-
tion of FasL is Pla dependent (Figure 1B). To show the specificity
of processing by Pla, we confirmed that Y. pestis is also able to
cleave plasminogen, but not TNF-a or GPIb-a (Figure S1C). InCelladdition, the requirement for proteolytically active Pla to degrade
FasL was demonstrated using a Pla active site point mutant, as
well as the ability of Pla to degrade both the human and mouse
variants of the protein (Figure S1D). To show sufficiency of Pla
for FasL degradation, we used E. coli to artificially produce Pla
and found that this pla-expressing strain is also able to degrade
FasL (Figure 1C).
The host matrix metalloprotease-7 (MMP-7) regulates FasL-
dependent apoptotic and inflammatory signaling by cleaving
FasL within its extracellular domain between amino acids K129
and Q130 to release a 25 kDa, soluble FasL (sFasL) fragment
from cell surfaces with minimal apoptotic activity (Hohlbaum
et al., 2000; Schneider et al., 1998; Tanaka et al., 1998). These
amino acids are contained within the Pla-cleaved array peptide
SLEKQIGH. While Pla also generates an initial 25 kDa fragment
similar to that produced by MMP-7, we observed that Pla is
able to further degrade this protein fragment beyond that
produced by MMP-7 (Figure 1B). The absence of accumulating
cleavage fragments and the loss of detectable FasL together
suggest that Pla cleaves FasL at multiple sites within its extra-
cellular domain that may fully inactivate FasL. Indeed, Y. pestis
is also able to degrade sFasL generated directly by MMP-7 in
a Pla-dependent manner (Figure 1D).
As FasL is a transmembrane protein localized to the surface of
host cells, it is likely that Pla would encounter this form of FasL
during infection following host cell contact by the bacteria.
Therefore, we incubated Y. pestiswith KFL-9 cells, a mammalian
lymphoblast cell line that produces membrane-bound FasL, and
examined the ability of Pla to degrade FasL associated with
these cells. We observed a Pla-dependent reduction of FasL
associated with whole cells, indicating that Pla is able to degrade
the membrane-bound variant of this protein in its native context
(Figure 1E). Since these cells also naturally release sFasL into the
culturemedium, we determined that Pla is able to degrade sFasL
shed from host cell surfaces as an alternative form of FasL that
could be encountered by Y. pestis within the host (Figure 1F).
Degradation of FasL by Pla Prevents Induction of
Apoptosis
A major consequence of the engagement of the Fas receptor by
FasL is the activation of caspase-3/7 as part of the extrinsic
pathway of apoptosis, resulting in death of the cell (Peter et al.,
2007). Therefore, to assess the functional impact of the Pla-
FasL interaction, we asked if Y. pestis-treated FasL is no longer
able to activate caspase-3/7 and induce apoptosis in eukaryotic
cells. FasL was untreated or incubated with either Y. pestis or
purified MMP-7, bacteria were removed by centrifugation, and
any remaining FasLwas added to Jurkat cells, a human leukemic
T cell linewidely used for the study of Fas signaling, or A549 cells,
a human type II pneumocyte cell line similar to cells that are
encountered by Y. pestis during pneumonic plague. We found
that, following treatment with either wild-type Y. pestis or
MMP-7, FasL is no longer able to induce caspase-3/7 activation
in either cell type (Figures 2A and S2). Conversely, FasL retains
its ability to activate caspase-3/7 under conditions where it re-
mains intact, including treatments with Y. pestis Dpla or MMP-
7 in the presence of themetalloprotease inhibitor phenanthroline.
To test if the inability of Pla-treated FasL to activate cas-
pase-3/7 corresponds with decreased cellular apoptosis, weHost & Microbe 15, 424–434, April 9, 2014 ª2014 Elsevier Inc. 425
Figure 1. Pla Is Necessary and Sufficient for Degradation of Full-Length and Soluble FasL
(A) Diagram of peptide array. After incubationwith purified His-Pla for peptide cleavage, a decrease in signal intensity from a given peptide represents its cleavage
by Pla. The peptide on the array corresponding to FasL is shown.
(B) Pla-dependent degradation of full-length FasL by Y. pestis. FasL processing was assessed over time by immunoblot with an anti-FasL antibody. The transient
25 kDa product produced by Pla is indicated with an arrow. Numbers to the left of each blot indicate molecular weight in kilodaltons (kDa).
(C) Pla is sufficient for degradation of FasL. FasL was incubated with E. coli either induced to produce Pla or carrying the corresponding empty expression vector.
(D) Pla-dependent processing of sFasL generated by MMP-7 following inhibition of MMP-7 using phenanthroline.
(E) Pla-dependent degradation of FasL from KFL-9 cells. Following detection of FasL, the immunoblot was stripped and GAPDHwas subsequently detected (as a
loading control).
(F) Degradation of sFasL endogenously shed from KFL-9 cell surfaces. sFasL was purified from conditioned media, incubated with either Y. pestis or E. coli
induced to produce Pla, and assessed by sFasL-specific ELISA. The mean and SE are shown; n = 4 for all groups, and this experiment was repeated three times.
***p < 0.001; Student’s t test. See also Figure S1 and Table S1.
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as above and then assessed changes in Annexin V staining, a
marker of host cell apoptosis, by flow cytometry. The processing
of FasL by either Pla or MMP-7 abrogates the induction of FasL-
mediated apoptosis, consistent with the lack of caspase-3/7
activation (Figures 2B and 2C). When incubated with MMP-7 in
the presence of phenanthroline or with Y. pestis Dpla, however,
FasL retains the ability to induce apoptosis. In total, these data
indicate that Y. pestis, through the activity of Pla, degrades the426 Cell Host & Microbe 15, 424–434, April 9, 2014 ª2014 Elsevier Inextracellular domain of FasL, which prevents the downstream
activation of caspase-3/7 and the subsequent induction of
Fas-mediated apoptotic cell death.
Pla Alters FasL Abundance in the Lungs during
Pneumonic Plague
While it is known that Pla is required for the progression of pneu-
monic plague, it is not yet clear which substrates of this protease
are relevant in vivo. As our data suggest that Pla may degradec.
Figure 2. Pla Abrogates FasL-Induced Caspase-3/7 Activation and Cellular Apoptosis
(A) FasL was pretreated with Y. pestis or MMP-7 before addition to Jurkat cells. Caspase-3/7 activation was measured based on binding of the fluorescent
substrate Ac-DEVD-AMC. Phenanthroline was used as an MMP-7 inhibitor.
(B) Jurkat cells were incubated with FasL and stained with the apoptosis marker Annexin V and propidium iodide (PI) as a viability dye. Representative plots are
shown. Percentage of total cells is indicated in each quadrant as viable (Q3; Annexin V, PI), early apoptotic (Q1; Annexin V+, PI), late-stage apoptotic (Q2;
Annexin V+, PI+), or necrotic (Q4; Annexin V, PI+).
(C) Percentage of apoptotic Annexin V+ cells (Q1 + Q2) for each treatment.
(A–C) The mean and SE are shown; n = 3 for all groups, and these experiments were repeated three times. *p < 0.05, **p < 0.01, ***p < 0.001; Student’s t test. See
also Figure S2.
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tribution of FasL in the lungs ofmice infectedwith Y. pestis. Since
the Y. pestis Dpla strain is attenuated during respiratory infec-
tions, to eliminate differences in CFU between the wild-type
and Dpla mutant we adjusted the input inoculum of the Dpla
strain given to mice. Because pulmonary infection with
Y. pestis Dpla leads to relatively steady-state CFU levels in the
lungs regardless of bacterial dose given (Figure S3A), C57BL/6
mice were infected via the intranasal route with either 104 CFU
wild-type or 108 CFU Dpla Y. pestis, doses that result in relatively
equivalent bacterial loads after 48 hr. At this time point, mice
were sacrificed, and the lungs were perfused, removed, and
homogenized for the quantification of FasL abundance by
ELISA. Although FasL is an acute-phase responsive protein
and is induced during infection (Kitamura et al., 2001; Neff
et al., 2005), we measured significantly reduced FasL levels in
the lungs of mice infected with wild-type Y. pestis compared to
Y. pestis Dpla (Figure 3A). We also assessed the distribution of
FasL at the local level by immunohistochemistry (IHC) and
observed reduced staining of FasL within the inflammatory
lesions of the lungs (where bacteria are found) during the wild-
type infection as compared to Dpla (Figure 3B). These results
are not due to differences in FasL transcript (Figure S3B); thus
in total these data demonstrate that Y. pestis alters FasL proteinCelllevels in the lungs, consistent with the hypothesis that Pla
cleaves FasL during pneumonic plague.
Degradation of FasL by Pla Enables Optimal Outgrowth
of Y. pestis in the Lungs
To test the influence of FasL-mediated signaling on the virulence
of Y. pestis in the presence or absence of Pla, we utilized
C57BL/6 FasLgld mice, which lack functional FasL and are un-
able to activate Fas (Takahashi et al., 1994). The absence of
Fas-FasL signaling in FasLgld mice can be either protective or
detrimental to the host during various bacterial infections
(Grassme´ et al., 2000; Matute-Bello et al., 2005b). We hypothe-
sized that if Pla contributes to the virulence of Y. pestis by inac-
tivating FasL, then no difference in bacterial burden would be
observed between wild-type and FasLgld mice when infected
with fully virulent Y. pestis. As expected, there is equivalent bac-
terial outgrowth in the lungs since FasL inactivation by Pla in
wild-typemice ismimicked in FasLgldmice (Figure 3C). However,
upon infection with Y. pestisDpla, the FasLgldmice would specif-
ically compensate for the loss of Pla-mediated FasL degradation
and is predicted to result in increased bacterial load compared to
wild-type mice. Indeed, the number of bacteria in the lungs is
significantly greater in FasLgld mice compared to wild-type
mice when infected with the Dpla strain at 48 hr and laterHost & Microbe 15, 424–434, April 9, 2014 ª2014 Elsevier Inc. 427
Figure 3. Loss of Fas-FasL Signaling Leads to Increased Y. pestis Dpla CFU in the Lungs
(A) Total FasL abundance in the lungs during pneumonic plague. At 48 hr postinoculation with PBS (mock), Y. pestis, or Y. pestis Dpla, FasL concentration was
measured from perfused lung homogenates by ELISA.
(B) Immunohistochemical staining of FasL in lung tissue. At 48 hr postinoculation, lung sections were stainedwith an anti-FasL antibody (brown). Hematoxylin was
used as a counterstain (blue). Representative images of inflammatory lesions are shown. Scale bars represent 50 mm.
(C and D) Wild-type C57BL/6 and functionally FasL-deficient C57BL/6 FasLgldmice were inoculated intranasally with Y. pestis (C) or Y. pestis Dpla (D). At various
time points postinoculation, mice were sacrificed and kinetics of infection determined by enumerating CFU per whole lungs. The mean and SE are shown; n = 10
for all groups representing data combined from two independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001; NS, not significant; one-way ANOVA (ELISA),
Mann-Whitney U test (CFU). See also Figure S3.
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the attenuated pgm strain of Y. pestis does not result in signif-
icant differences in CFU compared to wild-type mice, indicating
that FasLgld mice are not generally immunodeficient toward
Y. pestis (Figure S3C), and demonstrates the specific contribu-
tion of Pla-dependent FasL inactivation to virulence during pneu-
monic plague.
Pla Reduces FasL-Dependent Caspase-3/7 Activation in
the Lungs
As our data indicate that Y. pestis degrades FasL, we hypo-
thesized that Y. pestis may manipulate caspase-3/7 activation
in the lungs during the proinflammatory phase of pneumonic
plague.Wild-type or FasLgldmiceweremock infected or infected
with wild-type or Dpla Y. pestis, and after 48 hr the lungs
were perfused and homogenized, and active caspase-3/7
levels were determined. We found that during the proinflamma-
tory phase of pneumonic plague, caspase-3/7 activation relies
on the presence of FasL and is reduced to mock-infected
levels in FasLgldmice (Figure 4A). To examine caspase activation
independent of bacterial burden, mice were given increased
doses of Y. pestis Dpla to adjust output CFU in the lungs at
48 hr. We observed significantly reduced caspase-3/7 activation
in the lungs of mice infected with wild-type Y. pestis as
compared to CFU-normalized Y. pestis Dpla (108 CFU),
indicating that the presence of Pla decreases caspase-3/7428 Cell Host & Microbe 15, 424–434, April 9, 2014 ª2014 Elsevier Inactivation by preventing the induction of Fas signaling
(Figure 4A).
To determine the spatial induction of caspase-3 activation in
the lungs during infection with Y. pestis, we examined active
caspase-3 by IHC using fixed lung sections from mice infected
for 48 hr with Y. pestis or Y. pestis Dpla. Few caspase-3-positive
cells were found outside of the inflammatory lesions in wild-type
mice and in any pulmonary location in the FasLgldmice, confirm-
ing that caspase-3 activation is FasL dependent and localized to
the lesions where bacteria are present (Figure 4B). In addition,
we observed that caspase-3 activation is significantly reduced
in the presence of wild-type Y. pestis as compared to the Dpla
mutant (Figure 4C). Thus, the requirement of apoptotic signaling
to optimize innate host defenses during infection may explain
why decreased caspase-3/7 activity in FasLgld mice correlates
with increased Y. pestis Dpla CFU.
As previous studies have shown that the Yersinia T3SS
effector YopJ enhances apoptosis under in vitro conditions
(Matsumoto and Young, 2009; Yeretssian et al., 2008), to deter-
mine the relative impact of YopJ versus Pla on apoptosis during
pneumonic plague, we generated DyopJ and Dpla DyopJ
mutants of Y. pestis and examined caspase-3/7 activation in
the lungs of infectedmice. We found that YopJ has no significant
effect on caspase-3/7 activation during the proinflammatory
phase of pneumonic plague, regardless of the presence or
absence of Pla (Figure S4).c.
Figure 4. Caspase-3/7 Activation in the Lungs Requires FasL Signaling and Is Reduced by Pla
(A) Caspase-3/7 activity from perfused lung homogenates of mice infected with Y. pestis or Y. pestisDpla at standard or load-matched doses after 48 hr. n = 5 for
all groups, and the experiment was repeated three times. ‘‘CFU load (48 h)’’ indicates the approximate numbers of bacteria in the lungs under each condition at
the time of analysis.
(B) Active caspase-3 IHC of lung tissue frommice infected with Y. pestis or Y. pestis Dpla for 48 hr. Representative images of inflammatory lesions are shown with
positively stained cells for active caspase-3 indicated with arrows. Scale bars represent 30 mm.
(C) Quantification of active caspase-3 IHC as the percent of positively stained cells for each condition. The mean and SE are shown; n = 3 for all groups, and the
experiment was repeated three times. *p < 0.05, **p < 0.01; NS, not significant; one-way ANOVA. See also Figure S4.
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FasL Degradation
In addition to inducing cellular apoptosis, FasL signaling in the
lungs has been shown to mediate immune cell recruitment and
the secretion of cytokines (Hagimoto et al., 1999; Matute-Bello
et al., 2001, 2005b; Neff et al., 2005; Park et al., 2003). Therefore,
we hypothesized that inactivation of FasL by Pla may be used
by Y. pestis to subvert these immune responses. To test this,
we infected wild-type or FasLgld mice and after 48 hr measured
the abundance of inflammatory cytokines in the lungs. We found
that the overall inflammatory response is dampened in FasLgld
mice infected with Y. pestis Dpla, which produce lower levels
of IL-12, TNF, IFN-g, MCP-1, and IL-6 compared to wild-type
mice (Figure 5), suggesting that the loss of FasL signaling redi-
rects the host immune response during pneumonic plague. In
addition, when the bacterial loads are normalized between
the strains, we observe significantly lower cytokine levels in the
lungs of mice infected with wild-type Y. pestis compared to the
Dpla bacteria. This indicates that it is the presence of Pla that
alters the host inflammatory response, in part by preventing
the induction of Fas signaling, rather than simply due to differ-
ences in bacterial load.
Althoughwe observed little difference in overall lung pathology
between wild-type and FasLgldmice when infected with Y. pestis
or the Dplamutant (Figure S5A), we performed flow cytometry toCellquantify the Pla-dependent recruitment of immune cells to the
lungs during pneumonic plague. At 48 hr postinfection with
Y. pestis Dpla, we observed a lower percentage of monocytes
within the lungs of FasLgld mice compared to wild-type mice
(Figures S5B and S5C), consistent with the FasL-dependent
production of MCP-1 (Figure 5). To test whether these FasL-
dependent immune responses also affect lung injury, we
measured alveolar permeability and found reduced albumin
leakage in the bronchoalveolar lavage fluid of FasLgld mice
compared to wild-type animals, consistent with reports of
FasL-dependent lung injury in response to inflammatory stimuli
(Figure S5D) (Matute-Bello et al., 2005a; Neff et al., 2005). These
alterations of cytokines, immune cell populations, and tissue
permeability reinforce the model that the Pla-dependent manip-
ulation of FasL signaling disrupts the normal immune response,
which correlates with increased bacterial outgrowth and tissue
damage during primary pneumonic plague.
DEVDase Inhibition Recapitulates the Loss of FasL
during Pneumonic Plague
It is known that caspase-3/7-dependent apoptosis enhances
host defenses and restricts the outgrowth of various bacterial
pathogens during infection (Daigneault et al., 2012; Grassme´
et al., 2000; Jones et al., 2002). Therefore, to determine if the
outgrowth and cytokine phenotypes of FasL inactivation by PlaHost & Microbe 15, 424–434, April 9, 2014 ª2014 Elsevier Inc. 429
Figure 5. Loss of FasL Signaling Leads to a Dampened Host Cytokine Response upon Infection with Y. pestis Dpla
At 48 hr postinoculation with the indicated bacterial strains, lungs were perfused and homogenized. Levels of IL-12p70, TNF, IFN-g, MCP-1, and IL-6 were
measured in lung homogenates by cytometric bead array. Cytokine levels are represented as fold change relative to mock infection values. The mean and SE are
shown; n = 10 for all groups representing data combined from two independent experiments. ‘‘CFU load (48 h)’’ indicates the approximate numbers of bacteria in
the lungs under each condition at the time of analysis. *p < 0.05, **p < 0.01, and ***p < 0.001; Student’s t test. See also Figure S5.
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(which includes caspase-3/7), we treated mice with the inhibitor
Ac-DEVD-CMK and assessed caspase activation, bacterial
load, and cytokine levels in the lungs of infected mice (Ekert
et al., 1999).
To confirm specificity of inhibition, wemeasured the activation
of caspase-3/7, caspase-8, and caspase-1 in the lungs of mice.
Caspase-8 is activated through Fas signaling upon infection, yet
only downstream caspase-3/7 is specifically inhibited by DEVD
(Figure 6C). The pyroptosis factor caspase-1 is activated during
infection in a FasL-independent manner and thus is not affected
by DEVD treatment (Figure S6).We found that reduced DEVDase
activity results in increased CFU in the lungs following infection
with Y. pestis Dpla in a manner that recapitulates that observed
with FasLgld mice (Figures 6A and 6B). Likewise, the inflamma-
tory response to Y. pestis infection is dampened during DEVD
treatment to similar levels as seen in FasLgld mice (Figure 6D).
Therefore, the alteration of DEVDase-dependent factors, likely
caspase-3, is a major consequence of FasL inactivation by Pla.
DISCUSSION
Y. pestis employs multiple strategies to dampen early immune
responses during pneumonic plague. For example, several
T3SS Yop effectors restrict the ability of epithelial cells to upre-
gulate proinflammatory cytokines and chemokines (Price et al.,
2012), resulting in a delay in the induction of pulmonary inflam-
mation compared to that caused by other Gram-negative bac-
teria (Li and Yang, 2008). During the first 36 hr of the respiratory
infection, the lungs are relatively noninflammatory despite rapid
bacterial proliferation (Lathem et al., 2005). By 48 hr, however,
the pulmonary environment becomes highly proinflammatory
as the host responds to bacterial loads approaching 108 CFU.430 Cell Host & Microbe 15, 424–434, April 9, 2014 ª2014 Elsevier InThis biphasic disease supports two distinct pathogenic strate-
gies: in the early noninflammatory phase, Y. pestis avoids detec-
tion by innate immunity to allow for initial bacterial replication and
to establish infection in a new host environment. As bacteria
continue to replicate, detection by the host becomes inevitable,
and a proinflammatory phase commences. Therefore, the bacte-
rial virulence strategy shifts from evading to overwhelming innate
immunity. Within this proinflammatory phase, pla expression
increases (Lathem et al., 2014) and represents an additional
method for Y. pestis to modulate host immune responses.
Caspase-3/7 activation is known tomediate host inflammation
in the lungs during bacterial pneumonias (Hagimoto et al., 1999;
Park et al., 2003); however, our data show that Y. pestis modu-
lates these caspase-3/7-mediated immune responses via the
Pla protease (Figure 7). Specifically, through the degradation of
both FasL and sFasL, Pla inactivates FasL-dependent signaling,
and the Pla-dependent reduction in FasL abundance and
caspase-3 activation during infection is consistent with FasL
degradation by Pla in vivo. Cell death via apoptosis modulates
inflammatory cytokine production during infection and is
required for the host to initiate a fully effective innate immune
response (Labbe´ and Saleh, 2008; Matute-Bello et al., 2005a),
although this is likely to occur indirectly, downstream of FasL-
mediated cell death. We found that during pneumonic plague,
the production of several inflammatory cytokines is FasL depen-
dent and is affected by the presence of Pla. This cytokine
response presumably aids in the recruitment and/or activation
of immune cells as part of the host defense against infection
to control bacterial outgrowth, which Pla manipulates via the
degradation of FasL (Figure 7).
Consistent with our results using the caspase inhibitor DEVD,
prior studies have found increased bacterial burden in the lungs
during Streptococcus pneumoniae infection following treatmentc.
Figure 6. Inhibition of DEVDase Activity Enhances Bacterial Outgrowth and Reduces Cytokine Production
(A–D) Mice were infected with Y. pestis Dpla and treated with either the caspase inhibitor DEVD or vehicle alone via the intraperitoneal route. Bacterial burden (A),
caspase-3/7 activity (B), caspase-8 activity (C), and cytokine levels (D) were determined in the lungs at 48 hr postinoculation as described above. For analysis of
bacterial burden measurements, n = 10 for all groups representing data combined from two independent experiments. For caspase activity and cytokine
abundance measurements, the mean and SE are shown; n = 9 per group representing data combined from three independent experiments. *p < 0.05, **p < 0.01,
***p < 0.001; NS, not significant; one-way ANOVA. See also Figure S6.
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et al., 2003). Specifically, monocytes may play a role in host de-
fense here, since their recruitment is partially FasL dependent.
As seen by histology and flow cytometry in this and prior work
(Lathem et al., 2007; Pechous et al., 2013), neutrophils are the
most abundant cell type recruited to the lungs in a Pla-depen-
dent manner. Neutrophils accumulate around foci of bacterial
replication to form inflammatory lesions in the lungs and are at
least one cell type in which the activation of caspase-3 is limited.
It is not yet known, however, what other cell types may be
affected by the degradation of FasL or if other mechanisms of
cell death, such as pyroptosis or programmed necrosis, are
induced due to FasL degradation during infection.
Our findings demonstrate unappreciated protective roles for
FasL and caspase-3/7 signaling in the induction of host defenses
during Y. pestis infection of the lungs. The degradation of FasL by
Pla actively modulates these host defenses as part of the overall
approach to virulence of Y. pestis to alter host immuneCellresponses that allow for the increased fitness of this pathogen
during respiratory infection. The inactivation of the extrinisic
apoptosis signaling pathway by Pla provides a mechanism by
which Y. pestismay redirect the biphasic inflammatory response
to reduce apoptosis, potentially allowing for pyroptosis or
programmed necrosis to predominate during the later stages of
pneumonic plague. In addition, by reducing apoptosis during
infection, Pla may prevent the control and resolution of inflamma-
tion. Indeed, it isbecomingclear that themanipulationofcell death
is amajor strategy bywhich by bacterial pathogens enhance viru-
lence, although the specific mechanisms by which this occurs
appear to be different from species to species. For instance, it
was recently reported that the enteropathogenic E. coli T3SS
effector NleB disrupts FADD-mediated apoptosis downstream
of the engagement of Fas by FasL to counteract host defenses
and enhance colonization (Li et al., 2013; Pearson et al., 2013).
Given the host benefit of FasL signaling during pneumonia, the
use of Pla inhibitors, exogenous FasL, or agonistic anti-FasHost & Microbe 15, 424–434, April 9, 2014 ª2014 Elsevier Inc. 431
Figure 7. Model of FasL Inactivation by Pla during Pneumonic
Plague
Upon pneumonic infection with Y. pestis, Fas-FasL signaling is induced to
activate caspase-3 in the lungs. Caspase-3 activation is required for the host
to elicit an optimal inflammatory cytokine response as part of host innate
defenses. As part of its pathogenic strategy, Y. pestis utilizes Pla, which is
upregulated during later stages of disease to degrade FasL and prevent
caspase-3 activation. Downstream immune responses are altered, including
cytokine secretion and macrophage recruitment, resulting in the enhanced
virulence and outgrowth within the lungs of this bacterial pathogen.
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et al., 2005). The related proapoptotic ligand TRAIL has been
shown to be a therapeutic during pneumococcal pneumonia,
and TRAIL-deficient mice display increased bacterial burden in
the lungs, reduced apoptosis, and reduced caspase-3/7 activa-
tion (Steinwede et al., 2012). Thus, a greater understanding of
how apoptotic host cell death pathways initiate innate immune
responses in the lungs will aid the study of other bacterial pneu-
monias. This work describes a mechanism by which highly viru-
lent pathogens such asY. pestis control host cell death pathways
during pneumonia bymanipulating the activation of Fas signaling
through the degradation of FasL, and in part explains how Pla
contributes to the development of primary pneumonic plague.
EXPERIMENTAL PROCEDURES
Reagents, Bacterial Strains, and Growth Conditions
Reagentswere obtained fromSigma or VWR, unless otherwise indicated. Bac-
terial strains and plasmids used in this study are listed in Table S2. All exper-432 Cell Host & Microbe 15, 424–434, April 9, 2014 ª2014 Elsevier Iniments using select agent strains of Y. pestis were conducted in an approved
BSL-3/ABSL-3 facility at Northwestern University; experiments described in
Figures 1 and 2 and corresponding supplemental figures used the avirulent,
pCD1 variant of Y. pestis CO92. Y. pestis strains were cultured in liquid brain
heart infusion (BHI) medium at 37C with 2.5 mM CaCl2 when appropriate.
E. coli strains were cultured in Luria-Bertani (LB) medium supplemented with
ampicillin (100 mg/mL). Plasmids pSE380 and pMRK1 were introduced into
E. coli strain BL21. IPTG (100 mM) was added to induce pla expression from
pMRK1 (Kukkonen et al., 2001).
Purification and Activation of His-Pla
The gene encoding the mature form of Pla was cloned into the pQE30 expres-
sion vector (QIAGEN) to generate plasmid pWL223, and His-tagged Pla
protein was purified from E. coli BL21 (pREP4) under denaturing conditions
according to the QIAexpressionist kit protocol (QIAGEN). Following refolding
by dialysis in the presence of the detergent N-dodecyl-N,N-dimethyl-3-ammo-
nio-1-propanesulfonate, Pla was activated by agitation with E. coli K12 LPS as
previously described (Kukkonen et al., 2001).
Peptide Microarray
The protease profiler peptide microarray (JPT Peptide Technologies) contains
1,989 8-meric peptides derived from annotated protease cleavage sites and
1,536 randomly generated 15-meric peptides. Peptide substrates were
spotted in triplicate on each microarray (10,575 total data points) and distally
tagged with a phosphotyrosine moiety. To cleave peptides, a microarray slide
was incubated with purified and activated His-Pla (8 mg) for 5 hr at 37C. A
control slide was incubated with an equal amount of BSA-LPS mixture.
Fluorescence signal was detected by incubation with a mouse anti-phospho-
tyrosine antibody (Cell Signaling) followed by a fluorescently conjugated
secondary antibody (goat anti-mouse DyLight 649; Pierce). Relative peptide
cleavage was determined by calculating fluorescence ratios between His-
Pla and BSA treated slides. A 2-fold signal reduction threshold was used to
identify peptides as candidate Pla substrates.
Cell Culture
Jurkat cells and KFL-9 cells (undifferentiated lymphoblast cell line that consti-
tutively expresses human FasL) were grown in RPMI 1640 medium (Cellgro;
Mediatech) supplemented with penicillin-streptomycin (100 mg/mL) and 10%
heat-inactivated fetal bovine serum (HyClone; Thermo). A549 cells were grown
in minimal essential medium (MEM) supplemented with antibiotics and 10%
serum. Cells were grown at 37C in a 5% CO2 environment.
Immunoblot Analyses
Human recombinant FasL consisting of the extracellular portion of FasL (aa
103–281) with N-terminal FLAG-tag (Enzo Life Sciences) was used for
in vitro proteolysis assays. FasL protein (0.25 mg) was incubated at 37C
with either Y. pestis (4 3 107 CFU) or E. coli BL21 (8 3 107 CFU) in 20 mM
HEPES buffer (pH 7). At various times, bacteria were removed by centrifuga-
tion and supernatants and bacterial lysates separated by SDS-PAGE and
analyzed for FasL content by immunoblot using the anti-FasL antibody
N2C1 (GeneTex). To assess the degradation of sFasL by Pla, MMP-7
(0.5 mg; Genway Biotech) was first used to specifically process FasL
(0.15 mg) into sFasL by incubating for 1 hr at 37C. MMP-7 was then inhibited
by the addition of 1,10-phenanthroline (1 mM), followed by a second 1 hr incu-
bation with Y. pestis (6 3 107 CFU). To detect processing of FasL from cell
surfaces, KFL-9 cells were incubated with Y. pestis at an moi of 50, followed
by lysis with RIPA buffer. Cell lysates (50 mg) were analyzed by immunoblot
using anti-FasL (BD Biosciences, clone G247-4) and anti-GAPDH (Sigma,
#G9545) antibodies. Mouse FasL, GPIb-a (both 0.15 mg; R&D Systems), and
TNFa (0.15 mg; Invitrogen) were incubated with Y. pestis (4 3 107 CFU) for
1 hr and degradation assessed with anti-HA (Roche, clone 3F10) or anti-
TNFa (BioLegend, clone MAb1) antibodies. An anti-Pla antibody was used
as previously described (Houppert et al., 2013). All immunoblot experiments
were performed a minimum of two times.
FasL Quantification by ELISA
To quantify soluble FasL (sFasL), KFL-9 cells were cultured overnight in serum-
free RPMI to a final density of 1.4 3 105 cells/mL. The media supernatantc.
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concentrated approximately 30-fold using 10 kDa MWCO Centriprep YM-10
filters (Millipore). This concentrated sFasL (50 mL) was incubated with
Y. pestis or E. coli (8 3 108 CFU) for 3 hr at 37C in 20 mM HEPES (pH 7).
The supernatant was then used to perform an ELISA specific for human sFasL
(eBioscience). To assess FasL levels in vivo, lungs were perfused, removed,
and homogenized in PBS. FasL in lung homogenates was assessed using
the FasL Quantikine ELISA (R&D Systems). Samples were analyzed as dupli-
cates from five mice per treatment, and experiments were performed at least
twice.
Caspase Activity Assays
FasL was treated with Y. pestis or MMP-7 as described above. Treated FLAG-
FasL (2 mg/mL) was incubated with monoclonal anti-FLAG M2 antibody
(1.4 mg; Sigma) for 15 min to allow for FasL trimerization before incubation
with Jurkat (2 3 105) or A549 (2.5 3 105) cells, in triplicate, at 37C for 4 hr.
MMP-7 activity was inhibited with phenanthroline as indicated. Cells were
assessed using the caspase-3/7 activity assay kit (Sigma). To assess
caspase-3/7, caspase-1, and caspase-8 activities in vivo, lungs were perfused
and whole lung homogenates collected at 48 hr postinfection with Y. pestis.
Cells were washed with PBS, fixed, and analyzed with the corresponding
FLICA caspase detection kit (ImmunoChemistry Technologies). Samples
were analyzed as duplicates from five mice per treatment, and experiments
were performed at least twice.
Annexin V Staining
FasL was treated with Y. pestis or MMP-7 and incubated with anti-FLAG M2
antibody as described above. MMP-7 activity was inhibited with phenanthro-
line as indicated. Treated FasL (0.5 mg) was incubated with Jurkat (1 3 105)
cells, in duplicate, at 37C for 16 hr. Cells were washed with PBS and stained
with FITC-Annexin V and propidium iodide following the manufacturer’s
instuctions (eBioscience). Samples were analyzed using a BD FACSCanto II
flow cytometer.
Animal Infections
All procedures involving animals were carried out in compliance with protocols
approved by the Northwestern University institutional animal care and use
committee. Pathogen-free C57BL/6 and C57BL/6 FasLgldmice were obtained
from the Jackson Laboratory or bred at Northwestern University and were
infected with strains of Y. pestis as previously described (Lathem et al.,
2005). Mice (6–8 weeks old) were anesthetized with ketamine and xylazine
and inoculated by the intranasal route with Y. pestis or Y. pestis Dpla. A stan-
dard dose of approximately 1 3 104 CFU was administered except when
matching for bacterial load in the lungs at 48 hr, in which case mice were given
increased doses of Y. pestis Dpla. Infection of wild-type mice with 105 CFU of
Y. pestis Dpla approximates FasLgld mice given 104 CFU at 48 hr. Likewise,
infection of mice with 108 CFU of Y. pestis Dpla yields approximately the
same bacterial load after 48 hr as inoculating with 104 CFU of fully virulent
Y. pestis. Animals were sacrificed at various times postinfection, lungs homog-
enized in sterile PBS, and homogenates serially diluted onto BHI agar for CFU
enumeration. All animal infections were repeated at least twice and the data
combined. For caspase-3/7 inhibition studies, 200 mg of the caspase inhibitor
Ac-DEVD-CMK (American Peptide Company) or vehicle control was injected
via the intraperitoneal route at 0 and 24 hr postinoculation.
Cytokine Analysis
At 48 hr postinoculation with mock PBS, Y. pestis, or Y. pestis Dpla, levels of
IL-12p70, TNF, IFN-g, MCP-1, IL-10, and IL-6 were quantitatively established
from perfused lung tissue homogenates using the cytometric bead array tech-
nique (BD Cytometric Bead Array Mouse Inflammation Kit, BD Biosciences) as
specified by the manufacturer. Prior to analysis, homogenates were centri-
fuged at 16,000 3 g for one min to pellet tissue debris, and supernatants
were passed through a 0.22 mmfilter for sterilization. Data were analyzed using
BD Cytometric Bead Array Software.
Histopathology and Immunohistochemistry
At 48 hr postinoculation with PBS, Y. pestis, or Y. pestis Dpla, mice were sacri-
ficed and lungs inflated with 10% neutral-buffered formalin via cannulation ofCellthe trachea. Lungs were removed and fixed in 10% formalin overnight before
being embedded in paraffin for sectioning and staining. FasL (Enzo Life
Sciences, clone A11) and active caspase-3 (Cell Signaling, #9661) antibodies
were used for IHC. Caspase-3 activation was enumerated by counting the
fraction of positive cells in four biological replicate fields per set of conditions.
In all cases, three mice were used within each experimental group.
Statistical Analysis
All experiments were performed at least twice as indicated in figure legends,
and no data were excluded from analyses. In all cases, statistical means are
graphed and error bars represent SEM. Sample sizes (n) given represent
biological replicates in independent experiments unless stated otherwise.
Statistical significance was calculated by performing a two-tailed Mann-
Whitney U test for bacterial burden measurements, a one-way ANOVA with
Dunnett test for multiple comparisons, and Student’s two-tailed unpaired
t test for other analyses. p values of% 0.05 are considered significant; *p%
0.05, **p% 0.01, and ***p% 0.001.
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